News

Understanding the Latest Trends in Carvana Options Trading

Understanding the Latest Trends in Carvana Options Trading

Insights from the Options Market About Carvana

Investors are currently adopting a notably bearish stance toward Carvana (CVNA). This shifting trend is definitely something that retail traders should pay attention to.

Recent trading actions, as seen in the options activity, show that significant investments are being made, suggesting that something important might be on the way for CVNA.

So, how do we interpret these investor movements? Today’s options scans have uncovered a total of 11 unusual trades for Carvana, highlighting atypical market behavior.

The sentiment among larger investors is quite split—about 36% are leaning bullish, while a more substantial 54% are taking a bearish view.

Examining Price Targets and Trading Volume

When we dig deeper into the numbers, we find that 4 put options have been executed, totaling $517,362, while 7 call options reached $255,097. This split illustrates different risk appetites among traders.

Estimated Price Range for Carvana

Taking into account the volume and open interest of these trades, market analysts suggest that key players are focusing on a price range between $130 and $170 for Carvana over the past quarter.

Insights on Volume and Open Interest

As it stands, the average open interest for Carvana options is at 1,410, with a notable trading volume of 3,611. This data offers a thorough picture of trading behaviors from the previous month, especially regarding the activity in call and put options centered around specified strike prices.

In-Depth Look at Carvana's Options Activity

This ongoing evaluation brings us to last month’s trading figures within Carvana’s options market. Several significant trades have been identified, showing a mix of bullish and bearish movements.

Notable Recent Trades:

Here’s a breakdown of the most significant trades recently observed in the Carvana options market:

  • CVNA - PUT | SWEEP | Bullish | Expiring 11/15/24 | Ask: $10.55 | Bid: $10.15 | Strike Price: $130.00 | Total: $380.6K
  • CVNA - PUT | TRADE | Bearish | Expiring 10/18/24 | Ask: $27.5 | Bid: $26.3 | Strike Price: $170.00 | Total: $60.5K
  • CVNA - PUT | TRADE | Neutral | Expiring 10/18/24 | Ask: $24.55 | Bid: $23.55 | Strike Price: $170.00 | Total: $48.0K
  • CVNA - CALL | TRADE | Bullish | Expiring 09/20/24 | Ask: $12.7 | Bid: $12.35 | Strike Price: $135.00 | Total: $44.4K
  • CVNA - CALL | SWEEP | Bearish | Expiring 09/20/24 | Ask: $4.5 | Bid: $3.95 | Strike Price: $145.00 | Total: $39.9K

An Overview of Carvana's Business Operations

Carvana Co provides a cutting-edge e-commerce platform for buying and selling used cars. The company mainly earns revenue through retail vehicle sales, wholesale transactions, and related services.

Their services include financing options, sales of vehicle service contracts, auto insurance, and vehicle trade-ins, which form the backbone of their business model.

Carvana's Current Market Status

  • With a trading volume of 427,471, CVNA’s price has recently risen by 3.54%, currently standing at $146.92.
  • The RSI indicators show that the stock is neutral, sitting comfortably between overbought and oversold territories.
  • The next earnings announcement is expected to take place in about 45 days.

Analyst Views on Carvana

Over the past month, various industry analysts have expressed differing viewpoints on CVNA, suggesting an average target price around $182.33. Their predictions reflect a mix of optimism:

  • An analyst from JMP Securities has downgraded their outlook to Market Outperform with a target price of $200.
  • Evercore ISI Group keeps a neutral In-Line rating, with a target price of $157.
  • Stephens & Co. recently revised their estimate to Overweight, setting a target at $190.

While options trading involves higher risks compared to standard stock trading, it can offer the potential for greater profits. Knowledgeable options traders can manage risks by staying informed, scaling their trades cautiously, and using a blend of market indicators.

Frequently Asked Questions

What does the recent options activity for Carvana indicate?

The current options activity signals a bearish sentiment among larger investors, evident in the prevalence of put options.

What is the estimated price target for Carvana by analysts?

Analysts project an average target price nearing $182.33 for Carvana, which showcases a range of sentiments among the analysts.

How do options affect Carvana's stock performance?

Options trading can often hint at potential stock movements, reflecting investors' expectations for future price changes.

What does high open interest mean for investors?

A high open interest indicates strong investor interest and activity in certain options, potentially signaling upcoming volatility or a consensus on price movements.

Are there risks involved in trading options?

Yes, trading in options carries greater risks than direct stock trading, requiring a solid understanding of market mechanics and strategies to manage those risks effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading